Yet, researchers are working quite hard. And billions of dollars are being spent.
Quite recently, the FDA approved a new and VERY expensive cancer drug. As CNN reports:
“Vitrakvi is the first medication developed specifically to target tumors based on gene mutations, not their location in the body.”